Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease

INGELHEIM, Germany & INDIANAPOLIS, Ind.–(BUSINESS WIRE)–The European Commission (EC) approved Jardiance® (empagliflozin) for the treatment of adults with chronic kidney disease (CKD)…